Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002974 · ClinicalTrials.gov registry record · Phase 2
Whole-Body Hyperthermia Plus Chemotherapy in Treating Patients With Advanced Sarcoma
A Phase 2 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 2
- Development phase
- 34
- Enrollment target
NCT00002974 is a Phase 2 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 34 participants.
The verdict
NCT00002974, a Phase 2 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 34 participants
- Enrollment target
Study Summary
RATIONALE: Hyperthermia therapy kills tumor cells by heating them to several degrees above body temperature. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with whole-body hyperthermia may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of whole-body hyperthermia plus combination chemotherapy in treating patients who have advanced sarcoma that is metastatic or that cannot be surgically removed.
Interventions
- DRUG carboplatin
- DRUG etoposide
- DRUG ifosfamide
- PROCEDURE hyperthermia treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 1996-07 |
| Est. Completion | 2003-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002974
The ClinicalTrials.gov registry entry for NCT00002974 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which carboplatin is the first listed.
NCT00002974 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002974 about?
NCT00002974 is a clinical study titled "Whole-Body Hyperthermia Plus Chemotherapy in Treating Patients With Advanced Sarcoma". RATIONALE: Hyperthermia therapy kills tumor cells by heating them to several degrees above body temperature. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with whole-body hyperthermia may kill more tumor cells. PU...
What is the current status of trial NCT00002974?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 34 participants. The study started on 1996-07. Estimated completion is 2003-04.
What interventions are being tested in trial NCT00002974?
The interventions under investigation include: carboplatin (DRUG), etoposide (DRUG), ifosfamide (DRUG), hyperthermia treatment (PROCEDURE).
Who is sponsoring clinical trial NCT00002974?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.